Sanofi SA's Fiscal Year is From January To December.
The item "Number-of-Consecutive-Periods-With-Dividend-Growth" stands at 19.00 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Sanofi SA's third quarter, the item "Number of Consecutive Periods With Dividend Growth" stands at 19.00. This represents an increase of 5.56 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.67 percent compared to the value the year prior.
The 1 year change in percent is 26.67.
The 3 year change in percent is 171.43.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Number of Consecutive Periods With Dividend Growth | 905,699,262,464.00 |
![]() | Johnson & Johnson - Number of Consecutive Periods With Dividend Growth | 486,508,953,600.00 |
![]() | AbbVie Inc - Number of Consecutive Periods With Dividend Growth | 399,570,305,024.00 |
![]() | Roche Holding AG - Number of Consecutive Periods With Dividend Growth | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Number of Consecutive Periods With Dividend Growth | 280,205,508,085.11 |